Funding Opportunities

Small Project Submissions 2011

The OICR’s High Impact Clinical Trial (HICT) Program, together with its collaboration partner  the Ontario Translational Research Network (OTRN), are releasing a 3rd call for Small Project Submissions.

Small Project Submissions (SPS):

  • Are requests for support of specimen collection/analysis associated with a clinical trial which must:
    • Be sponsored/have external funding from other funding agencies;
    • Have received favorable external scientific peer review*;
    • Have all approvals in place, including ethics;
    • Meet the HICT Program's objectives and the OICR's strategic priorities**;
    • Have multicentre and multi-disciplinary collaborations.
  • Must be able to demonstrate an ability to complete the project by March 31st 2012 (no exceptions).

*Eligible external reviews include those by agencies such as NCI-CTEP, CCSRI, CBCF, Prostate Cancer Canada, NCIC CTG and CIHR, etc.  In addition, for trials that have not gone through peer-review through the previously listed agencies/groups, a peer-reviewed trial may have favourable opinions from a minimum of two external independent reviewers.  Departmental review within an institution is not considered external scientific peer-review. REB review is not considered external scientific peer-review. 

Available Funds: With a 2011-2012 budget of $150,000, the program aims to support 2-3 Small Projects each with a budget request of $50,000 - $100,000 (inclusive of overhead, if applicable).

Submission Deadline Date: Small Project Submissions must be submitted electronically to the HICT Program (HICTprojectsatoicr [dot] on [dot] ca) by August 10, 2011, 5 p.m. Submissions will receive a Submission Receipt response email. Submissions received after the deadline date/time will not be processed.

Review Date: Small Project Submissions will undergo an expedited review by non-conflicted HICT Program Management Committee (PMC) members during the September 9, 2011 PMC meeting. 

Notification of Awards:  All applicants will be informed of funding decision by end of September 2011.

Project Start Date: October 1, 2011

Project End Date: March 31, 2012

Project Report Date: May 15, 2012

Small Project 2011 Guidelines

Small Project 2011 Submission Form

 

Request for Proposals 2011

The OICR High Impact Clinical Trial (HICT) Program together with it collaborating partner, Cancer Care Ontario (CCO), is pleased to release ONTRECTs 2nd Request for Proposals. This initiative aims to support collaborative, multi-institutional, multidisciplinary projects that seek to address novel translational research questions in clinical trials. 

Available Funds: The program aims to support 2-3 projects. The program will make available up to $350,000/yr for fiscal periods of 2011-2012, 2012-2013, and 2013-2014. 

Projects developed through the current 2011 Request for Proposals will undergo a novel two tiered development and review process. Project Concepts are submitted for consideration by the HICT Program Management Committee. Eligible Project Concepts will be permitted to submit Full Proposals for review.

Deadlines:

Project Concepts due: May 16, 2011, 5 p.m.
Project Concept review period: May 17-May 30, 2011
Project Concept eligibility letters: May 31, 2011

Full Proposals due: June 30, 2011, 5 p.m.
Full Proposal review period: July 1-July 15, 2011 

Notification of Awards: Successful recipients will be informed by July 31, 2011 by way of NOA Letter outlining of projects to accrue expenses as of July 1, 2011.
 
Project Start Date: July 1, 2011             

RFP 2011 Guidelines

RFP 2011 Project Concept Form

RFP 2011 Full Proposal Form

RFP 2011 Full Proposal—Partner Site Form

HICT 2011 Full Proposal Budget Template

HICT Research Agreement Lead Site

HICT Research Agreement Partner Site

HICT Program Management Committee Members

 

HICT-Endorsed Trials Submissions 2011

The OICR High Impact Clinical Trial (HICT) Program is releasing this 2nd request for submissions of HICT Endorsed Trials (HET) to utilize Translational Research Team (TRT) funded resources.

Characteristics of an HICT Endorsed Trial are the following:

  1. A trial with translational research that meets HICT Program objectives and the OICR mandate. 
  2. The trial is sponsored/has external funding from other funding agencies and has undergone external peer-review.
  3. An institutional Principal Investigator requests infrastructure support from the institutional Translational Research Team (e.g., FTE, imaging or pathology service funds) to support the translational research trial activities with the approval of the TRT-PI.

HET requests must be related to a trial that has received favorable external peer-review, and has multicenter and multi-disciplinary collaborations. Eligible external reviews include those by agencies such as NCI-CTEP, CCSRI, CBCF, Prostate Canada, NCIC CTG and CIHR. In addition, for trials that have not gone through peer-review through the previously listed agencies/groups, a peer-reviewed trial may have favourable opinions from a minimum of two external independent reviewers prior to submission to HICT Program for endorsement. Departmental review within an institution is not considered external peer-review. REB review is not considered external scientific peer-review. However, the HET must have REB approval.


Available TRT Resources: HET applications will only be considered if there is underutilized TRT funded infrastructure (e.g., FTE time, funds, other TRT funded infrastructure) available at the TRT site. TRT resources must be reallocated to a HICT RFP when required. Each HET will be approved on a per trial, per TRT site basis.

Submission Deadline Date:  HET applications must be submitted electronically to the HICT Program (HICTprojectsatoicr [dot] on [dot] ca) by July 15 2011, 5 p.m.  All submissions will receive a Submission Receipt Response.  Submissions received after the deadline date/time will not be processed: no exceptions will be granted.

Review Date:  HET submissions for the 2011 Competition will undergo an expedited review by non-conflicted members of the HICT Program Management Committee during the September 9th 2011 PMC Meeting.  Resources will be further reviewed by Director, HICT Support Services and Director, Business Development Clinical Trials. 

Notification of Awards:  All applicants will be informed of decision by end of September 2011.

HET Start Date: October 1, 2011

HET Approval End Date: until trial completion or TRT resource has been reallocated to an HICT RFP Priority Project. HET will be reviewed annually to determine priority for continuation of support.

HET July 2011 Guidelines
HET July 2011 Form